Current Clinical Trials

These studies are available at Asheville Neurology Specialists for patients who qualify for participation.

Migraine Headache:

Allergan FORWARD – Evaluating Preventative Treatment Options for Chronic Migraine – Randomized, Open label study comparing BOTOX © vs. Topamax in subjects with no previous exposure to these medications – 12 month study, study visits and study drug provided

Parkinson’s Disease:

Biotie TOZ-PD – Study medication (Tozadanent) vs. placebo for subjects with moderate to severe Parkinson’s disease with wearing off of levodopa and levodopa-induced dyskinesia – 24 week double blind phase with 24 week open label extension – study visits and study drug provided; transportation assistance available

Kyowa iSTEP – Two doses of study medication (Istradefylline) vs. placebo for subjects with moderate to severe Parkinson’s disease with wearing off of levodopa, with or without dyskinesia – 16 week study, study visits and study drug provided, currently enrolling

Kyowa Open Label extension – Long term safety follow up with Istradefylline in patients who complete the double blind, iSTEP study – study visits and study drug provided, 12 month study

Planned studies in 2016 for Multiple Sclerosis; Acute, episodic and chronic Migraine Headache